Resistance of Cancer Cells to CTL-Mediated Immunotherapy

Nonfiction, Health & Well Being, Medical, Specialties, Oncology, Medical Science, Pharmacology
Cover of the book Resistance of Cancer Cells to CTL-Mediated Immunotherapy by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319178073
Publisher: Springer International Publishing Publication: June 20, 2015
Imprint: Springer Language: English
Author:
ISBN: 9783319178073
Publisher: Springer International Publishing
Publication: June 20, 2015
Imprint: Springer
Language: English

This comprehensive volume explores the latest research on the mechanisms of resistance in cancer cells to CTL-mediated immunotherapy. Chapter topics discuss cell-mediated immunity as the result of cytotoxic T-lymphocytes (CTL) directed specifically against cancer cells. In addition, the volume reviews how CTL mediate the cytotoxic activity, in large part, by the indication of apoptosis; hence, tumor cells develop anti-apoptotic mechanisms and thereby, resist CTL-induced apoptosis. In order for CTL-mediated antitumor immunotherapy to be effective, it is essential that agents directed against the resistant tumor cells sensitized cancer cells for CTL-mediated apoptosis. Examples of such agents discussed in the volume include are HDAC inhibitors, proteasome inhibitors, Bcl-2 family inhibitors, PARP, antibodies, and more.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This comprehensive volume explores the latest research on the mechanisms of resistance in cancer cells to CTL-mediated immunotherapy. Chapter topics discuss cell-mediated immunity as the result of cytotoxic T-lymphocytes (CTL) directed specifically against cancer cells. In addition, the volume reviews how CTL mediate the cytotoxic activity, in large part, by the indication of apoptosis; hence, tumor cells develop anti-apoptotic mechanisms and thereby, resist CTL-induced apoptosis. In order for CTL-mediated antitumor immunotherapy to be effective, it is essential that agents directed against the resistant tumor cells sensitized cancer cells for CTL-mediated apoptosis. Examples of such agents discussed in the volume include are HDAC inhibitors, proteasome inhibitors, Bcl-2 family inhibitors, PARP, antibodies, and more.

More books from Springer International Publishing

Cover of the book Cooperative Cognitive Radio Networking by
Cover of the book Best Practices in Manufacturing Processes by
Cover of the book Security and Cryptography for Networks by
Cover of the book Sustainable Agriculture Reviews by
Cover of the book Rain Formation in Warm Clouds by
Cover of the book Spirits in Transcultural Skies by
Cover of the book Ambivalences of Creating Life by
Cover of the book Utopia and Dystopia in Postwar Italian Literature by
Cover of the book REFAG 2014 by
Cover of the book Bridging People and Sound by
Cover of the book Ethnic Mobilization, Violence, and the Politics of Affect by
Cover of the book Measurement and Analysis in Transforming Healthcare Delivery by
Cover of the book The Physics of Galaxy Formation by
Cover of the book Fundamentals of Biomechanics by
Cover of the book Activation of Viruses by Host Proteases by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy